Skip to main content
. 2018 Oct 26;6(12):521–530. doi: 10.12998/wjcc.v6.i12.521

Table 1.

Baseline characteristics of the subjects

Characteristics Total group (n = 599) ALT ≤ 40 group (n = 272) 40 < ALT ≤ 80 group (n = 190) ALT > 80 group (n = 137) P-value
Age (yr) 37 (29, 44) 39 (31.25, 46) 37.5 (28, 43.25) 34 (28, 40.5) < 0.001
Male (%) 349 (58.3) 131 (48.2) 130 (68.4) 88 (64.2) < 0.001
ALT (U/L) 44 (28, 76) 26 (31, 33) 56 (48, 66) 127 (95, 218.5) < 0.001
AST (U/L) 32 (24, 48) 24 (20, 28) 36 (31, 42) 70 (55, 115.5) < 0.001
GGT (U/L) 25 (17, 41) 19 (14, 25) 30 (20, 41.25) 48 (30, 78) < 0.001
Cholesterol (mmol/L) 4.31 (3.84, 4.96) 4.35 (3.86, 4.95) 4.24 (3.75, 4.95) 4.34 (3.84, 4.99) 0.732
PLT (109/L) 182 (150, 217) 184 (155, 223) 177.5 (145.5, 212) 180 (149, 215) 0.215
INR 1 (1, 1.1) 1 (1, 1.1) 1 (0.99, 1.1) 1 (0.94, 1.1) 0.4
HBV DNA (log10IU/mL) 7.03 (4.24, 8.23) 4.77 (3.32, 7.78) 7.64 (5.72, 8.23) 8.03 (6.81, 8.23) < 0.001
S (%)
S0 264 (44.1) 128 (47.1) 80 (42.1) 56 (40.9)
S1 147 (24.5) 73 (26.8) 53 (27.9) 21 (15.3)
S2 96 (16) 35 (12.9) 29 (15.3) 32 (23.4)
S3 54 (9) 19 (7.0) 18 (9.5) 17 (12.4)
S4 38 (6.3) 17 (6.3) 10 (5.3) 11 (8.0)
Stage S0-1 fibrosis 411 (68.6) 201 (73.9) 133 (70) 77 (56.2) 0.001
Stage S2-4 fibrosis 188 (31.4) 71 (26.1) 57 (30) 60 (43.8)
APRI 0.53 (0.38,0.86) 0.38 (0.3, 0.49) 0.61 (0.44,0.8) 1.16 (0.88, 1.93) < 0.001
FIB-4 1.02 (0.72,1.47) 1.02 (0.72,1.37) 0.96 (0.66,1.55) 1.22 (0.82, 1.79) < 0.001
GPR 0.22 (0.15,0.38) 0.16 (0.11, 0.23) 0.24 (0.17,0.38) 0.42 (0.25, 0.68) < 0.001
King’s score 6.77 (4.31,11.49) 4.89 (3.54,7.03) 7.18 (4.58,11.58) 13.04 (9.81, 27.15) < 0.001
Forns index 6.48 (5.44,7.51) 6.33 (5.37,7.37) 6.57 (5.51,7.69) 6.65 (5.57, 7.57) 0.081

Data are expressed as the n (%) or median (interquartile range, IQR). ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; PLT: Platelet; S: Stage of fibrosis; GPR: Gamma-glutamyl transpeptidase (GGT)-to-platelet ratio; APRI: Aspartate aminotransferase (AST)-to-platelet (PLT) ratio index; FIB-4: Fibrosis index based on 4 factors; INR: International sensitivity index.